2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Neoplasms
2
Stroke
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease
1
Obesity
1
Multiple Sclerosis
1
Motor Activity
1
Leukemia
1
Fatigue
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Brain Injuries
1
Arthritis
1
Interventions
Exercise
25
Metformin
23
Tirzepatide
9
Resistance Training
8
Nutrition Assessment
8
Methods
8
Diet Therapy
8
Diet
8
Counseling
8
Surveys and Questionnaires
6
Early Intervention, Educational
6
Caloric Restriction
6
semaglutide
5
Liraglutide
5
Exenatide
5
Diet, Mediterranean
5
Blood Specimen Collection
5
Educational Status
4
Docosahexaenoic Acids
4
Bariatric Surgery
4
exemestane
3
Vitamin D
3
Therapeutics
3
Tamoxifen
3
Sugars
3
Standard of Care
3
Observation
3
Naltrexone
3
Letrozole
3
Dexamethasone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Obesity
×
Exergaming
×
Clear all
NCT02152462
2020-02-10
POWER
Georgetown University
Phase 2
Completed
150 enrolled